Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Immunogen Inc
(NQ:
IMGN
)
29.32
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 1, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunogen Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 01, 2023
From
ImmunoGen, Inc.
Via
Business Wire
Dow Jones Hits 2023 High, Nasdaq Slips; Tesla Cybertruck, Salesforce In Focus: Weekly Review
December 01, 2023
Software earnings were strong, while the Fed is shifting toward rate cuts.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
December 01, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
ImmunoGen Inc. (NASDAQ: IMGN) Near Top of Volume Charts in Thursday Trading
November 30, 2023
Via
Investor Brand Network
Health Care Company AbbVie Announces Acquisition of Immunogen
November 30, 2023
Via
Benzinga
Where Immunogen Stands With Analysts
November 20, 2023
Via
Benzinga
ImmunoGen Stock Nearly Doubled On Thursday: What Happened?
November 30, 2023
Shares of ImmunoGen Inc. close to doubled this morning after AbbVie Inc. said it will buy the cancer therapies company for $10.1 billion.
Via
Talk Markets
Why Abbvie Stock Popped Today
November 30, 2023
The company announces a major deal worth over $10 billion.
Via
The Motley Fool
Nasdaq Falls Over 100 Points; Cracker Barrel Shares Slide After Q1 Results
November 30, 2023
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index gaining around 300 points on Thursday. The Dow traded up 0.88% to 35,742.35 while the NASDAQ fell 0.79% to 14,145.17. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 30, 2023
Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.
Via
Benzinga
What 4 Analyst Ratings Have To Say About Immunogen
November 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 30, 2023
Via
Benzinga
Crude Oil Falls Sharply; Kroger Posts Upbeat Earnings
November 30, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 100 points on Thursday. The Dow traded up 0.85% to 35,729.88 while the NASDAQ fell 0.71% to 14,156.60. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
ImmunoGen's Flagship Cancer Therapy Draws AbbVie's Attention With $10.1B Deal
November 30, 2023
AbbVie Inc (NYSE: ABBV) has agreed to acquire ImmunoGen Inc (NASDAQ: IMGN) and its flagship cancer therapy Elahere (mirvetuximab soravtansine-gynx), a first-in-class antibody-drug conjugate (ADC)...
Via
Benzinga
Why Is Soligenix (SNGX) Stock Up 285% Today?
November 30, 2023
Soligenix stock is rising higher on Thursday with heavy trading of SNGX shares after getting FDA approval for a Phase 2 clinical trial.
Via
InvestorPlace
Exposures
Product Safety
Minim (MINM) Stock Soars 77% After Receiving Nasdaq Deficiency Notice
November 30, 2023
Minim stock is taking off with heavy trading of MINM shares on Thursday despite the company getting a delisting warning.
Via
InvestorPlace
Why Is ImmunoGen (IMGN) Stock Up 81% Today?
November 30, 2023
ImmunoGen stock is taking off on news that AbbVie is acquiring all outstanding shares of IMGN in a $10.1 billion acquisition deal.
Via
InvestorPlace
AbbVie To Buy ImmunoGen, Cancer Drug Maker, In $10.1 Billion Cash Deal
November 30, 2023
IMGN stock soared after AbbVie agreed to buy ImmunoGen for $10.1 billion, offering a rich premium for the maker of cancer drug Elahere.
Via
Investor's Business Daily
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday
November 30, 2023
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Jumps Around 200 Points; US Core PCE Inflation Slows In October
November 30, 2023
U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 200 points on Thursday. Following the market opening Thursday, the Dow traded up 0.56% to 35,630.09 while the...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
IMGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ImmunoGen, Inc. Is Fair to Shareholders
November 30, 2023
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 30, 2023
Via
Benzinga
These Three Biotech Stocks Are Trading At A Discount
November 23, 2023
Investors exposed to the biotech sector have seen mixed results this year.
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
November 17, 2023
Via
Benzinga
CRISPR Therapeutics Stock Earns 88 RS Rating On U.K. Regulator News
November 17, 2023
CRISPR Therapeutics sees its Relative Strength Rating enter the 80-plus level.
Via
Investor's Business Daily
Madrigal Pharmaceuticals Stock Clears Benchmark, Hits 80+ RS Rating
November 17, 2023
Madrigal Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 86.
Via
Investor's Business Daily
9 Health Care Stocks With Whale Alerts In Today's Session
November 16, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 15, 2023
Via
Benzinga
ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies London Healthcare Conference
November 02, 2023
From
ImmunoGen, Inc.
Via
Business Wire
ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results
November 02, 2023
From
ImmunoGen Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.